Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-25 @ 4:15 AM
NCT ID:
NCT07274020
Eligibility Criteria:
Inclusion Criteria:
* Adults ≥18 years of age.
* Confirmed diagnosis of non-cystic fibrosis bronchiectasis by high-resolution CT (HRCT).
* History of ≥2 bronchiectasis exacerbations in the previous 12 months.
Exclusion Criteria:
* Diagnosis of cystic fibrosis-related bronchiectasis.
* Known hypersensitivity or contraindication to fluoroquinolones (including moxifloxacin).
* Severe hepatic impairment or severe renal impairment (eGFR \<30 mL/min/1.73 m²).
* Pregnancy or breastfeeding.
* History of significant QT prolongation, arrhythmia, or concurrent use of QT-prolonging drugs.
* Use of long-term suppressive antibiotics for bronchiectasis in the past 3 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07274020
Study Brief:
Protocol Section:
NCT07274020